TY - JOUR
T1 - The Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat)
T2 - Driving Multicentric Research and Implementation Science
AU - The Latin America the Caribbean Consortium on Dementia (LAC-CD)
AU - Ibanez, Agustin
AU - Yokoyama, Jennifer S.
AU - Possin, Katherine L.
AU - Matallana, Diana
AU - Lopera, Francisco
AU - Nitrini, Ricardo
AU - Takada, Leonel T.
AU - Custodio, Nilton
AU - Sosa Ortiz, Ana Luisa
AU - Avila-Funes, José Alberto
AU - Behrens, Maria Isabel
AU - Slachevsky, Andrea
AU - Myers, Richard M.
AU - Cochran, J. Nicholas
AU - Brusco, Luis Ignacio
AU - Bruno, Martin A.
AU - Brucki, Sonia M.D.
AU - Pina-Escudero, Stefanie Danielle
AU - Okada de Oliveira, Maira
AU - Donnelly Kehoe, Patricio
AU - Garcia, Adolfo M.
AU - Cardona, Juan Felipe
AU - Santamaria-Garcia, Hernando
AU - Moguilner, Sebastian
AU - Duran-Aniotz, Claudia
AU - Tagliazucchi, Enzo
AU - Maito, Marcelo
AU - Longoria Ibarrola, Erika Mariana
AU - Pintado-Caipa, Maritza
AU - Godoy, Maria Eugenia
AU - Bakman, Vera
AU - Javandel, Shireen
AU - Kosik, Kenneth S.
AU - Valcour, Victor
AU - Miller, Bruce L.
N1 - Funding Information:
The consortium was supported by the Multi-partner Consortium to Expand Dementia Research in Latin America [ReDLat, by National Institutes of Health, National Institutes of Aging (R01 AG057234), Alzheimer’s Association (SG-20-725707), Rainwater Charitable Fundation-Tau, and Global Brain Health Institute]. AI was partially supported by grants from Takeda CW2680521, Alzheimer’s Association GBHI ALZ UK-20-639295, CONICET, ANID/FONDAP/15150012, Sistema General de Regalías (BPIN2018000100059), Universidad del valle (CI 5316), and The Inter-American Development Bank (IDB). ASI was also partially supported by ANID/FONDAP/15150012. CD-A was partially supported by 2018-AARG-591107 and ANID/FONDEF
Funding Information:
Funding. The consortium was supported by the Multi-partner Consortium to Expand Dementia Research in Latin America [ReDLat, by National Institutes of Health, National Institutes of Aging (R01 AG057234), Alzheimer's Association (SG-20-725707), Rainwater Charitable Fundation- Tau, and Global Brain Health Institute]. AI was partially supported by grants from Takeda CW2680521, Alzheimer's Association GBHI ALZ UK-20-639295, CONICET, ANID/FONDAP/15150012, Sistema General de Regal?as (BPIN2018000100059), Universidad del valle (CI 5316), and The Inter-American Development Bank (IDB). ASI was also partially supported by ANID/FONDAP/15150012. CD-A was partially supported by 2018-AARG-591107 and ANID/FONDEF ID20I10152. The contents of this publication are solely the responsibility of the authors and do not represent the official views of these institutions.
Funding Information:
A key ambition of our consortium is to create harmonized approaches to dementia diagnosis in order to allow multi-country comparisons. First, we developed diagnostic recommendations (relevant clinical, neuropsychological, and behavioral assessments), for diagnosis of AD and FTD across LAC even where there are no available resources required for classification of dementias (121). Then, supported by the Inter-American Developmental Bank (IDB) and a GBHI pilot funding, we develop a best practice manual for dementia diagnosis1. The manual has been highlighted by the Alzheimer’s & Dementia journal (122) and involves more than 40 leaders from expert panels and authors. The manual provides a regional approach to dementia in the region, its epidemiology and different health systems, clinical and neuropsychological assessments and a chapter on carers.
Publisher Copyright:
© Copyright © 2021 Ibanez, Yokoyama, Possin, Matallana, Lopera, Nitrini, Takada, Custodio, Sosa Ortiz, Avila-Funes, Behrens, Slachevsky, Myers, Cochran, Brusco, Bruno, Brucki, Pina-Escudero, Okada de Oliveira, Donnelly Kehoe, Garcia, Cardona, Santamaria-Garcia, Moguilner, Duran-Aniotz, Tagliazucchi, Maito, Longoria Ibarrola, Pintado-Caipa, Godoy, Bakman, Javandel, Kosik, Valcour and Miller.
PY - 2021/3/11
Y1 - 2021/3/11
N2 - Dementia is becoming increasingly prevalent in Latin America, contrasting with stable or declining rates in North America and Europe. This scenario places unprecedented clinical, social, and economic burden upon patients, families, and health systems. The challenges prove particularly pressing for conditions with highly specific diagnostic and management demands, such as frontotemporal dementia. Here we introduce a research and networking initiative designed to tackle these ensuing hurdles, the Multi-partner consortium to expand dementia research in Latin America (ReDLat). First, we present ReDLat's regional research framework, aimed at identifying the unique genetic, social, and economic factors driving the presentation of frontotemporal dementia and Alzheimer's disease in Latin America relative to the US. We describe ongoing ReDLat studies in various fields and ongoing research extensions. Then, we introduce actions coordinated by ReDLat and the Latin America and Caribbean Consortium on Dementia (LAC-CD) to develop culturally appropriate diagnostic tools, regional visibility and capacity building, diplomatic coordination in local priority areas, and a knowledge-to-action framework toward a regional action plan. Together, these research and networking initiatives will help to establish strong cross-national bonds, support the implementation of regional dementia plans, enhance health systems' infrastructure, and increase translational research collaborations across the continent.
AB - Dementia is becoming increasingly prevalent in Latin America, contrasting with stable or declining rates in North America and Europe. This scenario places unprecedented clinical, social, and economic burden upon patients, families, and health systems. The challenges prove particularly pressing for conditions with highly specific diagnostic and management demands, such as frontotemporal dementia. Here we introduce a research and networking initiative designed to tackle these ensuing hurdles, the Multi-partner consortium to expand dementia research in Latin America (ReDLat). First, we present ReDLat's regional research framework, aimed at identifying the unique genetic, social, and economic factors driving the presentation of frontotemporal dementia and Alzheimer's disease in Latin America relative to the US. We describe ongoing ReDLat studies in various fields and ongoing research extensions. Then, we introduce actions coordinated by ReDLat and the Latin America and Caribbean Consortium on Dementia (LAC-CD) to develop culturally appropriate diagnostic tools, regional visibility and capacity building, diplomatic coordination in local priority areas, and a knowledge-to-action framework toward a regional action plan. Together, these research and networking initiatives will help to establish strong cross-national bonds, support the implementation of regional dementia plans, enhance health systems' infrastructure, and increase translational research collaborations across the continent.
KW - Alzheimer's disease
KW - Latin America
KW - SDOH
KW - SES
KW - dementia
KW - fronto-temporal dementia
KW - genetics
KW - implementation science
UR - http://www.scopus.com/inward/record.url?scp=85103097770&partnerID=8YFLogxK
U2 - 10.3389/fneur.2021.631722
DO - 10.3389/fneur.2021.631722
M3 - Review article
AN - SCOPUS:85103097770
SN - 1664-2295
VL - 12
JO - Frontiers in Neurology
JF - Frontiers in Neurology
M1 - 631722
ER -